Interview with CEO Nils Brünner and CEO Ole Thastrup (2cureX)

BioStock has interviewed CEO Nils Brünner, Scandion Oncology, and CEO Ole Thastrup, 2cureX, about the Eurostars project on antiestrogen resistance.

The full interview is freely available here: https://www.biostock.se/2020/06/scandion-oncology-och-2curex-erhaller-bidrag-fran-eurostars/

 

Latest news & press releases
20.Feb 21

Great interest at our Year-end 2020 webcast
Thank you to all attendees who joined our live Year-end 2020 webcast & Q&...

18.Feb 21

Year-end Report 2020: Scandion Oncology is poised for the future
Scandion Oncology A/S (”Scandion Oncology” or “the Company”) hereby publishes...

18.Feb 21

Invitation to Scandion Oncology A/S live webcast on February 19, 2021
Invitation to Scandion Oncology A/S live webcast on February 19, 2021 We h...

Co-funded by the Horizon 2020 programme of the European Union
Co-funded by the COSME programme of the European Union
Privacy and Cookie Policy